PerpEquitiesEquity
PFE perpetual futures
Pfizer Inc. tracked across crypto venues with normalized contract specs.
Price chart
23.79▼ 0.08%
23.6823.7023.7223.7423.7623.7823.80
01:37 PM02:18 PM03:00 PM03:41 PM04:22 PM
24/7 perp mark · BingX (PFE-USDT)
Auto: market closed → highest-volume perp venue
Trading data
Perpetual market activity
Venues
2
Live markets
2/2
24h volume
$168k
Open interest
$2k
Best liquidity
$102k
BingX
Tightest spread
+4.2 bps
BingX
Highest volume
$164k
BingX
Settlement mix
USDT · 2/2
Best Liquidity
PFETightest Spread
PFEHighest Volume
PFECompany data
Company fundamentals
Market cap
$135.8B
Updated 3h ago
Revenue
$63.3B
Trailing 12 months
Net income
$7.5B
Trailing 12 months
Free cash flow
$9.5B
Trailing 12 months
Profit margin
11.8%
P/E
18.2
P/S
2.1
Revenue estimate
$61.7B
Next fiscal year
Revenue growth
-1%
Next fiscal year
Fundamental detail
Annual + quarterlyLatest revenue$62.6B
Net margin+12.4%
Free cash flow$9.1B
Net debt$66.3B
PeriodRevenueGrowthNet incomeFCF
2020$41.7B+1%$9.2B$11.6B
2021$81.3B+95%$22.1B$29.9B
2022$100.3B+23%$31.4B$26.0B
2023$59.6B-41%$2.1B$4.8B
2024$63.6B+7%$8.0B$9.8B
2025$62.6B-2%$7.8B$9.1B
PeriodGross marginOperating marginNet marginROEROA
2020+71.7%+21.8%+22.0%+14.5%+5.9%
2021+57.7%+25.6%+27.2%+28.7%+12.2%
2022+61.9%+37.4%+31.3%+32.8%+15.9%
2023+50.9%+8.9%+3.6%+2.4%+0.9%
2024+65.8%+25.9%+12.6%+9.1%+3.8%
2025+70.3%+24.7%+12.4%+9.0%+3.7%
PeriodCashDebtNet debtCurrent ratio
2020$1.8B$38.3B$36.5B1.35
2021$1.9B$37.0B$35.1B1.40
2022$416.0M$34.9B$34.4B1.22
2023$2.9B$70.8B$68.0B0.91
2024$1.0B$67.0B$66.0B1.17
2025$1.1B$67.4B$66.3B1.16
PeriodMarket capEnterprise valueP/SP/E
2020$204.5B$241.0B4.922.3
2021$330.7B$365.8B4.114.9
2022$287.4B$321.8B2.99.2
2023$162.5B$230.5B2.776.7
2024$150.3B$216.2B2.418.7
2025$141.5B$207.8B2.318.3
PeriodRevenueGrowthNet incomeFCF
Q2 2024$13.3B+2%$24.0M$-2.4B
Q3 2024$17.7B+31%$4.5B$6.1B
Q4 2024$17.8B+22%$403.0M$5.8B
Q1 2025$13.7B-8%$3.0B$1.8B
Q2 2025$14.7B+10%$2.9B$-1.2B
Q3 2025$16.7B-6%$3.5B$4.0B
Q4 2025$17.6B-1%$-1.6B$4.5B
Q1 2026$14.5B+5%$2.7B$2.2B
PeriodGross marginOperating marginNet marginROEROA
Q2 2024+62.1%+14.1%+0.2%+0.0%+0.0%
Q3 2024+60.8%+28.1%+25.3%+4.8%+2.0%
Q4 2024+73.0%+32.2%+2.3%+0.5%+0.2%
Q1 2025+71.7%+33.7%+21.6%+3.3%+1.4%
Q2 2025+64.3%+24.4%+19.9%+3.3%+1.4%
Q3 2025+74.9%+21.3%+21.3%+3.8%+1.7%
Q4 2025+70.0%+21.0%-9.4%-1.9%-0.8%
Q1 2026+67.3%+27.9%+18.6%+3.0%+1.3%
PeriodCashDebtNet debtCurrent ratio
Q2 2024$1.1B$68.7B$67.6B0.86
Q3 2024$1.1B$66.6B$65.5B1.00
Q4 2024$1.0B$63.6B$62.6B1.17
Q1 2025$1.4B$61.3B$59.9B1.26
Q2 2025$1.6B$61.8B$60.2B1.16
Q3 2025$1.3B$61.7B$60.4B1.28
Q4 2025$1.1B$67.4B$66.3B1.16
Q1 2026$1.7B$64.5B$62.8B1.25
PeriodMarket capEnterprise valueP/SP/E
Q2 2024$159.9B$227.5B12.01679.8
Q3 2024$164.0B$229.5B9.39.2
Q4 2024$150.3B$213.0B8.591.6
Q1 2025$143.8B$203.7B10.512.1
Q2 2025$137.8B$198.0B9.411.9
Q3 2025$135.6B$196.0B8.19.6
Q4 2025$141.5B$207.8B8.1-21.5
Q1 2026$158.0B$220.8B10.914.8
Refreshed 3h ago
Research data
Estimates, events and peers
Estimates
6 periodsFY 2026$61.7B-1%19 analysts
FY 2027$59.1B-6%19 analysts
FY 2028$54.6B-13%22 analysts
FY 2029$53.2B-15%15 analysts
FY 2030$53.5B-14%11 analysts
Q2 2026$14.4B-1%9 analysts
Events
Earnings · dividends · splits2026-08-04EarningsRevenue est. $14.4B
2026-07-24Dividend0.43 dividend
2026-05-08Dividend0.43 dividend
2026-05-05EarningsRevenue est. $13.8B
2026-02-03EarningsRevenue est. $16.8B
2026-01-23Dividend0.43 dividend